S&P 500   3,329.62 (+0.39%)
DOW   29,348.10 (+0.17%)
QQQ   223.38 (+0.49%)
AAPL   318.73 (+1.11%)
FB   222.14 (+0.17%)
MSFT   167.10 (+0.56%)
GOOGL   1,479.52 (+2.02%)
AMZN   1,864.72 (-0.70%)
CGC   24.89 (+2.43%)
NVDA   249.28 (+0.14%)
BABA   227.43 (+1.56%)
MU   57.66 (-0.03%)
GE   11.81 (-0.25%)
TSLA   510.50 (-0.58%)
AMD   50.93 (+2.33%)
T   38.38 (+0.92%)
ACB   2.13 (-0.93%)
F   9.16 (-0.11%)
NFLX   339.67 (+0.31%)
PRI   128.43 (+0.05%)
BAC   34.71 (-0.03%)
GILD   62.98 (-0.35%)
DIS   144.33 (-0.54%)
S&P 500   3,329.62 (+0.39%)
DOW   29,348.10 (+0.17%)
QQQ   223.38 (+0.49%)
AAPL   318.73 (+1.11%)
FB   222.14 (+0.17%)
MSFT   167.10 (+0.56%)
GOOGL   1,479.52 (+2.02%)
AMZN   1,864.72 (-0.70%)
CGC   24.89 (+2.43%)
NVDA   249.28 (+0.14%)
BABA   227.43 (+1.56%)
MU   57.66 (-0.03%)
GE   11.81 (-0.25%)
TSLA   510.50 (-0.58%)
AMD   50.93 (+2.33%)
T   38.38 (+0.92%)
ACB   2.13 (-0.93%)
F   9.16 (-0.11%)
NFLX   339.67 (+0.31%)
PRI   128.43 (+0.05%)
BAC   34.71 (-0.03%)
GILD   62.98 (-0.35%)
DIS   144.33 (-0.54%)
S&P 500   3,329.62 (+0.39%)
DOW   29,348.10 (+0.17%)
QQQ   223.38 (+0.49%)
AAPL   318.73 (+1.11%)
FB   222.14 (+0.17%)
MSFT   167.10 (+0.56%)
GOOGL   1,479.52 (+2.02%)
AMZN   1,864.72 (-0.70%)
CGC   24.89 (+2.43%)
NVDA   249.28 (+0.14%)
BABA   227.43 (+1.56%)
MU   57.66 (-0.03%)
GE   11.81 (-0.25%)
TSLA   510.50 (-0.58%)
AMD   50.93 (+2.33%)
T   38.38 (+0.92%)
ACB   2.13 (-0.93%)
F   9.16 (-0.11%)
NFLX   339.67 (+0.31%)
PRI   128.43 (+0.05%)
BAC   34.71 (-0.03%)
GILD   62.98 (-0.35%)
DIS   144.33 (-0.54%)
S&P 500   3,329.62 (+0.39%)
DOW   29,348.10 (+0.17%)
QQQ   223.38 (+0.49%)
AAPL   318.73 (+1.11%)
FB   222.14 (+0.17%)
MSFT   167.10 (+0.56%)
GOOGL   1,479.52 (+2.02%)
AMZN   1,864.72 (-0.70%)
CGC   24.89 (+2.43%)
NVDA   249.28 (+0.14%)
BABA   227.43 (+1.56%)
MU   57.66 (-0.03%)
GE   11.81 (-0.25%)
TSLA   510.50 (-0.58%)
AMD   50.93 (+2.33%)
T   38.38 (+0.92%)
ACB   2.13 (-0.93%)
F   9.16 (-0.11%)
NFLX   339.67 (+0.31%)
PRI   128.43 (+0.05%)
BAC   34.71 (-0.03%)
GILD   62.98 (-0.35%)
DIS   144.33 (-0.54%)
Log in

NASDAQ:AVCO - Avalon Globocare Stock Price, Forecast & News

$1.90
+0.03 (+1.60 %)
(As of 01/17/2020 04:00 PM ET)
Today's Range
$1.87
Now: $1.90
$1.94
50-Day Range
$1.44
MA: $1.85
$2.31
52-Week Range
$1.40
Now: $1.90
$13.50
Volume154,100 shs
Average Volume127,192 shs
Market Capitalization$143.96 million
P/E RatioN/A
Dividend YieldN/A
Beta0.77
Avalon GloboCare Corp., together with its subsidiaries, engages in integrating and managing healthcare services and resources in the United States. It provides medical related consulting services and develops Avalon Cell and Avalon Rehab platforms that cover the areas of regenerative medicine, cell-based immunotherapy, and exosome technology. The company also develops proprietary diagnostic and therapeutic products leveraging exosome technology; and markets and distributes proprietary exosome isolation systems and related products, as well as provides development services for hospitals. In addition, it owns and operates real property. The company has a strategic partnership with Weill Cornell Medical College to co-develop technologies and bio-production of chimeric antigen receptor-T Therapy; a research and licensing agreement with Massachusetts Institute of Technology to develop technology for cellular therapy; and strategic partnership with GE Healthcare to enhance standardized automation and bio-production for cellular medicines. Avalon GloboCare Corp. is headquartered in Freehold, New Jersey.

Industry, Sector and Symbol

Industry Management consulting services
Sub-IndustryN/A
SectorBusiness Services
Current SymbolNASDAQ:AVCO
CUSIPN/A
Phone732-780-4400

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$1.56 million
Book Value$0.15 per share

Profitability

Net Income$-7,770,000.00
Net Margins-1,081.80%

Miscellaneous

Employees8
Market Cap$143.96 million
Next Earnings Date3/24/2020 (Estimated)
OptionableNot Optionable

Receive AVCO News and Ratings via Email

Sign-up to receive the latest news and ratings for AVCO and its competitors with MarketBeat's FREE daily newsletter.


5G Flaw Exposed: $5 Stock Holds Key To $12 Trillion Opportunity (Ad)


A devastating technical glitch could crush the next generation of wireless technology before it even launches. With trillions of dollars and millions of jobs at stake, one company with the "5G fix" could put as much as $234,770 in your pocket this year. But Wall Street vultures are circling... you'll need to move quickly or risk missing this $5 bargain.

Avalon Globocare (NASDAQ:AVCO) Frequently Asked Questions

What is Avalon Globocare's stock symbol?

Avalon Globocare trades on the NASDAQ under the ticker symbol "AVCO."

How were Avalon Globocare's earnings last quarter?

Avalon Globocare Corp (NASDAQ:AVCO) released its earnings results on Thursday, November, 14th. The company reported ($0.04) EPS for the quarter. The firm earned $0.38 million during the quarter. Avalon Globocare had a negative return on equity of 164.86% and a negative net margin of 1,081.80%. View Avalon Globocare's Earnings History.

When is Avalon Globocare's next earnings date?

Avalon Globocare is scheduled to release their next quarterly earnings announcement on Tuesday, March 24th 2020. View Earnings Estimates for Avalon Globocare.

Has Avalon Globocare been receiving favorable news coverage?

News stories about AVCO stock have trended positive this week, InfoTrie Sentiment Analysis reports. InfoTrie identifies positive and negative press coverage by reviewing more than six thousand news and blog sources in real-time. The firm ranks coverage of public companies on a scale of -5 to 5, with scores closest to five being the most favorable. Avalon Globocare earned a news sentiment score of 3.0 on InfoTrie's scale. They also assigned news articles about the company a news buzz of 10.0 out of 10, indicating that recent press coverage is extremely likely to have an effect on the stock's share price in the immediate future. View News Stories for Avalon Globocare.

Are investors shorting Avalon Globocare?

Avalon Globocare saw a increase in short interest in December. As of December 31st, there was short interest totalling 774,000 shares, an increase of 24.2% from the December 15th total of 623,200 shares. Based on an average trading volume of 122,100 shares, the days-to-cover ratio is currently 6.3 days. Approximately 3.5% of the company's shares are sold short. View Avalon Globocare's Current Options Chain.

Who are some of Avalon Globocare's key competitors?

What other stocks do shareholders of Avalon Globocare own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Avalon Globocare investors own include Axsome Therapeutics (AXSM), Allena Pharmaceuticals (ALNA), Amarin (AMRN), Guardant Health (GH), Immunomedics (IMMU), Intra-Cellular Therapies (ITCI), Regenxbio (RGNX), Viking Therapeutics (VKTX), Myovant Sciences (MYOV) and Acasti Pharma (ACST).

Who are Avalon Globocare's key executives?

Avalon Globocare's management team includes the folowing people:
  • Dr. David K. Jin, CEO, Pres & Director (Age 51)
  • Ms. Luisa Ingargiola, Chief Financial Officer (Age 52)
  • Ms. Meng Li, COO, Sec. & Director (Age 41)
  • Dr. Yu Zhou M.D., Ph.D., Co-CEO & Director of GenExsome

How do I buy shares of Avalon Globocare?

Shares of AVCO can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

What is Avalon Globocare's stock price today?

One share of AVCO stock can currently be purchased for approximately $1.90.

How big of a company is Avalon Globocare?

Avalon Globocare has a market capitalization of $143.96 million and generates $1.56 million in revenue each year. Avalon Globocare employs 8 workers across the globe.View Additional Information About Avalon Globocare.

What is Avalon Globocare's official website?

The official website for Avalon Globocare is http://www.avalon-globocare.com/.

How can I contact Avalon Globocare?

Avalon Globocare's mailing address is 4400 Route 9 South Suite 3100, Freehold NJ, 07728. The company can be reached via phone at 732-780-4400 or via email at [email protected]


MarketBeat Community Rating for Avalon Globocare (NASDAQ AVCO)

Community Ranking:  2.5 out of 5 (star star half star)
Outperform Votes:  130 (Vote Outperform)
Underperform Votes:  132 (Vote Underperform)
Total Votes:  262
MarketBeat's community ratings are surveys of what our community members think about Avalon Globocare and other stocks. Vote "Outperform" if you believe AVCO will outperform the S&P 500 over the long term. Vote "Underperform" if you believe AVCO will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 1/17/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel